University of California, San Francisco: Lung Neoplasms trials
The registry lists 15 Lung Neoplasms studies with University of California, San Francisco as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 4Phase 2 5No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLCCompletedNCT03982459Not applicableResults posted
- Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung CancerTerminatedNCT03232892Phase 2Results posted
- Lung Cancer Screening CT for FirefightersWithdrawnNCT06836414Not applicable
- CONNECTing to LungCareActive, not recruitingNCT06213532Not applicable
- Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung CancerWithdrawnNCT04061590Phase 2
- Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung CancerTerminatedNCT04005144Phase 1
- Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsCompletedNCT03867916Not applicable
- Lung Cancer Screening: A Multilevel InterventionCompletedNCT03862001Not applicable
- T-Cell PET Imaging With [18F]F-AraG in Lung CancerWithdrawnNCT03311672Phase 2
- Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT03087448Phase 1
- Virtual Intervention for Lung CancerWithdrawnNCT01684696Not applicable
- Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesWithdrawnNCT00738335Phase 1
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
- Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerCompletedNCT00003072Phase 2